Is Triple Phase III Triumph for AbbVie's Risankizumab In Psoriasis Good Enough?

 
• By Alex Shimmings
Carnival End_1200
Too late to the party for risankizumab • Source: Shutterstock

More from Clinical Trials

More from R&D